Citius Pharmaceuticals Inc. (CTXR) last month volatility was 8.06%: Don’t Ignore this Blaring Warning Signal

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) started the day on May 03, 2021, with a price increase of 7.73% at $2.37. During the day, the stock rose to $2.52 and sunk to $2.2501 before settling in for the price of $2.20 at the close. Taking a more long-term approach, CTXR posted a 52-week range of $0.77-$2.90.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Meanwhile, its Annual Earning per share during the time was 20.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 42.00%. This publicly-traded company’s shares outstanding now amounts to $134.70 million, simultaneously with a float of $68.11 million. The organization now has a market capitalization sitting at $306.16 million. At the time of writing, stock’s 50-day Moving Average stood at $1.91, while the 200-day Moving Average is $1.31.

Citius Pharmaceuticals Inc. (CTXR) Ownership Facts and Figures

Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Citius Pharmaceuticals Inc.’s current insider ownership accounts for 9.14%, in contrast to 6.60% institutional ownership.

Citius Pharmaceuticals Inc. (CTXR) Earnings and Revenue Records

In the latest quarterly report released, which was put into the public domain on 12/30/2020, the organization reported -$0.15 earnings per share (EPS) for the three months, lower than the consensus estimate (set at $0.16) by -$0.31. This company achieved a return on equity of -60.46. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.

Citius Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 42.00% and is forecasted to reach 0.31 in the upcoming year.

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Trading Performance Indicators

Let’s observe the current performance indicators for Citius Pharmaceuticals Inc. (CTXR). It’s Quick Ratio in the last reported quarter now stands at 1.60. The Stock has managed to achieve an average true range (ATR) of 0.16.

A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .


In the same vein, CTXR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.47, a figure that is expected to reach -0.07 in the next quarter, and analysts are predicting that it will be 0.31 at the market close of one year from today.

Technical Analysis of Citius Pharmaceuticals Inc. (CTXR)

If we take a close look at the recent performances of Citius Pharmaceuticals Inc. (NASDAQ: CTXR), its last 5-days Average volume was 11.47 million that shows plunge from its year to date volume of 12.12 million. During the previous 9 days, stock’s Stochastic %D was recorded 87.82% While, its Average True Range was 0.17.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Raw Stochastic average of Citius Pharmaceuticals Inc. (CTXR) in the period of the previous 100 days is set at 72.54%, which indicates a major fall in contrast to 85.29% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 85.12% that was lower than 96.36% volatility it exhibited in the past 100-days period.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

We do not sell or share your information with anyone.